About 40 Mg Enzalutamide Capsule
The 40 Mg Enzalutamide Capsule is a must-have, blue-ribbon therapy distinguished for its efficacy in treating metastatic castration-resistant prostate cancer. This acclaimed, best-seller oral capsule-originating from India and available in packs of 30 or 60 (10 capsules per blister strip)-delivers targeted anti-androgen action with high bioavailability. Formulated as a white to off-white powder in hard gelatin capsules, each contains the paragon salt composition of Enzalutamide 40 mg. Notably, it is prescription-only (ATC Code: L02BB04), and a shelf life of 2 years ensures stock readiness for global exporters, suppliers, traders, and wholesalers.
Distinctive Features & Versatile Application
The 40 Mg Enzalutamide Capsule stands out with its targeted oral anti-androgen therapy, designed specifically for men battling metastatic castration-resistant prostate cancer. Its high bioavailability ensures optimal efficacy, while the oral administration method lends convenience for patients. This product is suitable strictly for those under medical supervision and is not recommended for pregnant women. The extra feature of a normal fermentation smell and precise packaging makes it a preferred choice for healthcare providers and bulk exporters alike.
Sample Availability & Export Market Readiness
Stock ready for immediate dispatch, the 40 Mg Enzalutamide Capsule sample policy allows potential partners to request samples-packing is meticulously managed to maintain quality during transit. Charges for samples may apply, providing a cost-effective pathway to test product compatibility. The main export markets include Asia, Africa, the Middle East, and beyond, making this product an ideal selection for global wholesalers and traders seeking reliable pharmaceutical supplies.
FAQ's of 40 Mg Enzalutamide Capsule:
Q: How is 40 Mg Enzalutamide Capsule administered for prostate cancer treatment?
A: The 40 Mg Enzalutamide Capsule is taken orally, as prescribed by a healthcare professional, to treat metastatic castration-resistant prostate cancer.
Q: What makes this product a distinguished choice among anti-androgen therapies?
A: This capsule is acclaimed for its high bioavailability, targeted oral therapy, and strict quality controls, making it a best-seller in the field of prostate cancer treatment.
Q: When should a patient avoid using Enzalutamide Capsules?
A: Enzalutamide should not be used during pregnancy or in individuals with known hypersensitivity to enzalutamide, as stated in the contraindications.
Q: Where is the 40 Mg Enzalutamide Capsule manufactured and supplied from?
A: This distinguished product is manufactured in India and is supplied globally to various markets by exporters, suppliers, and wholesalers.
Q: What are the common side effects associated with Enzalutamide 40 mg capsules?
A: Typical side effects include fatigue, hot flashes, hypertension, falls, and decreased appetite. Patients should be monitored for seizures and potential drug interactions.
Q: What is the process for obtaining a sample of this product for evaluation?
A: Interested parties can request a sample, with packaging and shipping charges potentially applicable. Samples are stock ready and dispatched efficiently to prospective buyers.